Biotech · Private company
Mallinckrodt ARD LLC
Track this companyFree. Adds Mallinckrodt ARD LLC to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- MNK-1411Phase 2 · Muscular Dystrophy, DuchenneClinicalTrials.gov · fetched Nov 12, 2026
- Acthar GelIdiopathic Focal Segmental GlomerulosclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Acthar GelMultiple Sclerosis, Relapsing-RemittingClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular DystrophyPHASE2 · TERMINATED · started Jul 27, 2018ClinicalTrials.gov NCT03400852 · fetched Nov 12, 2026
- Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)PHASE4 · TERMINATED · started May 22, 2017ClinicalTrials.gov NCT03126760 · fetched Nov 12, 2026
- Acthar for Treatment-Resistant or Treatment-Intolerant ProteinuriaPHASE4 · COMPLETED · started Oct 10, 2016ClinicalTrials.gov NCT02633046 · fetched Nov 12, 2026